Related Experiment Video
Updated: May 28, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Association of Vitamin D Deficiency as an Independent Risk Factor for Myocardial Infarction and Its Therapeutic
Abirami Balasubramanian1, Keerthi Kunchala2, Aaisha Shahbaz3
1Internal Medicine, Stanley Medical College, Chennai, IND.
Abstract:
Vitamin D deficiency is a highly prevalent condition globally and has emerged as a significant risk factor for the development of coronary artery disease (CAD). Although its role in the regulation of phospho-calcic metabolism is well established, its involvement in the evolution of myocardial infarction (MI) is yet to be fully understood. Vitamin D deficiency is a manageable condition, and a reasonable time to assess and commence treatment is crucial, as the patient presents with acute myocardial infarction (AMI). This article discusses the various mechanisms through which vitamin D may prevent MI, including its role in the development of atherosclerosis, as well as its cardioprotective effects. Cardiomyocytes and vascular smooth muscle have exhibited the presence of the vitamin D receptor (VDR) on the surface. Vitamin D deficiency also plays a crucial role in upregulating inflammatory cytokines and activating the renin-angiotensin-aldosterone system (RAAS). This review aims to explore the implications of vitamin D deficiency on MI by assessing multiple observational studies and randomized controlled trials. The findings suggest a positive correlation between low serum vitamin D levels and the incidence of MI, based on observational studies. Additionally, studies reflect that hypovitaminosis D predisposes AMI patients to post-infarction complications and cardiac remodeling. Contrastingly, the impact of vitamin D supplementation on mitigating the risk of MI is debatable, as evidenced by interventional studies. Future research is thus warranted to showcase the promising approach of vitamin D supplementation in lowering the risk of MI, alongside investigating optimal dosing and evaluating long-term impacts on cardiovascular morbidity and mortality.
More Related Videos
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Related Concept Videos
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cardiovascular Drugs: Classification based on Therapeutic Indications